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Abstract PC12 cells growth-arrested with bafilomycin A1 died 
showing apoptotic chromatin condensation in the nuclei. The 
bafdomycin At-induced chromatin condensation was preceded by 
neurite outgrowth (NOG), required higher concentrations of 
bafilomycin A1 than NOG, and was suppressed by cycloheximide 
and aurintricarboxylic acid. NH4C! (10 raM), another acido- 
tropic pH perturbing agent, neither induced apoptotic hromatin 
condensation by itself nor suppressed that induced by bafilomycin 
A1, suggesting that bafilomycin Ai-induced apoptosis occurs 
independently of intracellular pH in PC12 cells. 
K,y words: Bafilomycin A1; Apoptosis; Vacuolar 
H -ATPase; NH4C1; PC12 cell 
I. Introduction 
Vacuolar type H--ATPases (V-ATPases) are present on the 
membranes of acidic organelles, such as synaptic vesicles, 
cbromaffin granules, platelet-dense granules, secretary gran- 
ul,.:s, lysosomes and the trans-Golgi network, and maintain 
m acidic environment thereby pumping protons using the 
energy of ATP hydrolysis [1]. The acidic pH in such organelles 
is proposed to be responsible for important cellular functions 
lil, e endocytosis, exocytosis, and intracellular t afficking [2]. 
V ATPases are also present on the plasma membranes of at 
le,~st some types of cells (e.g. osteoclasts [3], macrophages [4] 
ard some tumor cells [5]) thereby acidifying the surrounding 
m,~dium and/or maintaining the cytosolic pH by extruding 
p~ otons out of the cells. However, their role in cell differentia- 
ti,,n, cell growth and cell death remains unknown. Using a 
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recently discovered potent selective inhibitor of vacuolar H +- 
ATPase, bafilomycin A1 [6], we suggested the possible involve- 
ment of vacuolar H+-ATPase in cell differentiation a d in cell 
growth: bafilomycin A1 not only induced neurite outgrowth 
(NOG) of PC12 cells [7] and differentiation of M1 cells into 
macrophage-like phagocytic ells [8] but also arrested cell 
growth of various cells in culture [9]. Similar observations 
on the growth inhibitory effect of bafilomycin A1 have also 
been reported [10,11]. Furthermore, we reported that bafilo- 
mycin A1 induces apoptosis in PC12 cells [12]. Recently, 
apoptosis has been reported to be induced in several types 
of cells by a series of V-ATPase inhibitors [13]. 
Herein, we report full details on the apoptotic nature of the 
cell growth inhibition by bafilomycin A1 in PC12 cells as 
compared with that by NH4C1. 
2. Materials and methods 
2.1. Mater&& 
Bafilomycin A1 and mouse 7S nerve growth factor (NGF) were 
kindly provided by Professor K. Altendorf (University of Osnabrtick, 
Germany) and K. Hayashi (Gifu College of Pharmacy, Japan), respec- 
tively. Most of the other chemicals used in this study including 
Hoechst 33342, Hoechst 33258 and aurintricarboxylic a id (ATA) 
were obtained from Sigma (St. Louis, MO, USA). Most of the lipo- 
philic compounds used in this study, including bafilomycin A1, were 
dissolved in DMSO and applied to cells at a final DMSO concentra- 
tion of 1%. 
2.2. Cell culture 
Rat pheochromocytoma PC12 cells (RCB 009) were obtained from 
RIKEN Cell Bank (Tsukuba, Japan) and cultured in Dulbecco's mod- 
ified Eagle's medium (Flow Laboratories) upplemented with 10% 
fetal calf serum (M.A. Laboratory) and 5% horse serum (CosmoBio, 
Japan) at 37°C in 5% CO> 
2.3. Measurement of cell viability 
Cell viability was assessed by dual fluorescence staining with pro- 
pidium iodide and fluorescein diacetate (FDA) [14]. Cells plated in 24- 
well culture dishes were incubated in medium containing propidium 
iodide (50 nM) and FDA (0.15 nM) at 37°C for 10 min, then washed 
and observed under epifluorescence microscopy (Olympus, BH2-RFK 
or IMT-2-21CA3 with B-excitation); viable cells showed green fluo- 
rescence due to fluorescein accumulated bythe cytosolic hydrolysis of 
FDA, while the nuclei of dead cells showed red fluorescence bypro- 
pidium iodide taken up because the permeability barrier to the dye 
had been lost. All data shown are the averages (mean + S.D.) of trip- 
licate experiments. 
2.4. Measurement of chromosome condensation 
Apoptosis was first assessed morphologically as chromatin conden- 
sation by staining with Hoechst 33342 (or 33258) [15]. PC12 cells 
plated in 24-well culture dishes at a density of 3-5× 104 cells/ml 
were cultured under various conditions and then stained with Hoechst 
dye (10 Ixg/ml) at 37°C for 1 h, washed once with Dulbecco's modified 
Eagle's medium by centrifugation (3000×g for 5 min) and observed 
under epifluorescence microscopy (Olympus, BH2-RFK or IMT-2- 
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21CA3 with U-excitation) directly or after fixation with 2% glutaral- 
dehyde. About 150 cells were counted per well, and the percent of 
cells with chromatin condensation was calculated. All data are shown 
as the averages (mean + S.D.) of duplicate or triplicate xperiments. 
2.5. Detection of DNA fragmentation 
Apoptosis was also assessed by fragmentation f DNA into a series 
of nucleosome sets resulting in ladder formation on agarose gel elec- 
trophoresis [16]. PC12 cells plated in 90-mm dishes at a density of 
about 3× 10 ~ cells/ml and treated with various conditions for indi- 
cated periods were washed with Dulbecco's modified Eagle's medium, 
scraped from dishes with a rubber policeman, and collected by cen- 
trifugation at 2500×g for 5 min. The resultant cell pellets were re- 
suspended in PBS, lysed in a 100 I-tl lysis buffer (10 mM Tris-HC1 (pH 
7.4), 10 mM EDTA, and 0.5% Triton X-100) at 4°C for 20 min. After 
centrifugation at 10000 rpm for 30 min, the supernatants were trans- 
ferred to conical centrifuge tubes, and treated with RNase A (400 ~tg/ 
ml, at 37°C for 2 h) and proteinase K (200 lag/ml, at 37°C for 1 h), 
sequentially. The DNA was applied onto a 2% agarose gel for elec- 
trophoresis and stained with 0.5 ~g/ml of ethidium bromide for I0 
min. 
2.6. Neurite outgrowth (NOG) assay 
The extent of NOG of PC12 cells plated in 24-well culture dishes at 
a density of 3-5 × 104 cells/ml under various conditions was estimated 
as described previously [7]. Briefly, a neurite was defined as a process 
more than 1.5 times longer than the cell body judged from photo- 
graphs taken under phase contrast microscopy (Olympus, Tokyo). 
About 150 cells were counted per well, and the percent of cells with 
neurites was calculated. All data shown are the averages (mean + S.D.) 
of duplicate or triplicate xperiments. 
2. 7. Measurement of intracellular pH 
Measurement of cytosolic pH was performed essentially according 
to [9] using 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein (BCECF) 
[17] as a pH probe. Briefly, after overnight culture of cells in micro- 
plates (1-3 × 104 cells/ml), the medium was changed to one containing 
2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein t traacetoxymethyles- 
ter (BCECF-AM), cultured for an additional hour, and the cells 
were washed with Hanks' solution buffered with 20 mM HEPES 
(Hanks'-HEPES). Medium with or without drugs was added, then 
the cells were further incubated for 1 h. After briefly washing the cells 
with Hanks'-HEPES, fresh medium of the same composition was 
added and the fluorescence mitted by cells in 5% CO2 95% air at 
37°C was viewed using an IMT-2-21-CA3 inverted fluorescence micro- 
scope (Olympus, Tokyo) through a SIT camera, after excitation at 450 
K. Kinoshita et al./FEBS Letters 398 (1996) 61~56 
nm, and analyzed with an ARGUS-100/pH image processor (Hama- 
matsu Photonics, Hamamatsu). The cytosolic pH was estimated using 
standards prepared in situ under the same condition as those for 
culture. For the measurement of vacuolar (lysosomal) pH, cells were 
loaded overnight with fluorescein-labeled dextran instead of BCECF 
and then processed essentially as described above for the measurement 
of fluorescence mitted from lysosomes [18,19]. 
3. Results 
3.1. Induction of chromatin condensation i  PC12 cells by 
bafilomycin A1 
Both bafilomycin Aa (->100 nM) and NH4C1 ( -10  mM) 
almost completely arrested the growth of various cells in cul- 
ture including PC12 cells [9]; flow cytometric analysis sug- 
gested that they stay apparently at the G0/G1 phase of the 
cell division cycle (unpublished observation). The treatment 
with bafilomycin A1 decreased the number of viable PC12 
cells time- and dose-dependently, as in serum-free medium 
(Fig. 1A,B). However, the viability of the cells did not de- 
crease by treatment with NH4C1 up to 10 mM (Fig. 1A). In 
serum-free medium, PC12 cells die as a consequence of apop- 
tosis [20]. Therefore, we next examined the nuclear morphol- 
ogy of the cells by staining them with Hoechst 33258 (for 
nuclear condensation) (Fig. 2). Unlike the cells treated with 
solvent (DMSO) (Fig. 2A), the nuclear morphology of the 
cells treated with bafilomycin A1 (Fig. 2B) showed bright 
chromatin condensation i dicative of apoptosis as seen in cells 
cultured in the absence of serum (24 h) (Fig. 2D and [20]): 
many small bright dots indicative of apoptotic body forma- 
tion were obvious in PC12 cells growth-arrested with bafilo- 
mycin A1 in later stages. On the other hand, cells treated with 
10 mM NH4C1 did not show any sign of apoptotic nuclear 
morphology at any time point tested (Fig. 2C). 
3.2. Time course and dose response of induction of chromatin 
condensation by bafilomycin A1 
Fig. 3 shows the time course and dose response of the in- 
duction of chromatin condensation by bafilomycin A1 corn- 
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Fig. 1. Time course and dose response of survival of bafilomycin Al-treated PC12 cells. Cells were scored for percent survival as described in 
Section 2 after incubation for the indicated periods at different concentrations of bafilomycin A1. A: Time course. (e) control (complete me- 
dium); (O) 7.8 nM bafilomycin At; (m) 31 nM bafilomycin A1; ([]) 125 nM bafilomycin A1; (zx) serum-free medium; (x) 10 mM NHaCI. 
B: Dose response• (O) 0 h; (O) 12 h; (m) 24 h; ([2) 36 h; (A,) 48 h; (a)  60 h. 
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Fi~,,. 2. Morphological features of PCI2 cells stained with Hoechst 33258. Cells were stained with Hoechst 33258 and observed under epifluores- 
ce1~ce microscopy after incubation in the following conditions: (A) 1% DMSO, 36 h; (B) bafilomycin A1 (125 nM) in 1% DMSO, 36 h; 
(C] NH4C1 (10 mM), 36 h; (D) serum-free medium, 24 h. The length of the bar corresponds to 50 lam. The cells in B and D show bright fluo- 
re~.:ence of apoptotic hromatin condensation with occasional small structures resembling apoptotic bodies. 
pa red with those for the induction of NOG [7]. As shown in 
Fi;. 3A, the morphological change of NOG induction pre- 
ce, led that of chromatin condensation by 10-12 h and ap- 
peared maximal at about 36 h at a concentration of 125 
nM. The induction of apoptosis required higher concentra- 
tions of bafilomycin A1 than the induction of NOG, and 
aFoptotic change was maximally induced at the concentra- 
tions (->100 nM) of bafilomycin A~ that were about 3 times 
higher than those required for NOG (30-100 nM). NH4C1 
d~es not show any activity of NOG at any concentra- 
ti~ ,n [7]. 
A] was inhibited completely by CHX at concentrations higher 
than 125 ~g/ml. However, the same concentration f CHX did 
not inhibit chromatin condensation i duced in cells cultured 
in serum-free medium, which also confirmed published find- 
ings [20]. Fig. 4B shows the effect of ATA, an inhibitor of 
endonuclease [21], on the bafilomycin A] (125 nM)-induced 
chromatin condensation. ATA (up to 400 nM) similarly in- 
hibited the bafilomycin Al-induced apoptotic hromatin con- 
densation. ATA also inhibited ose-dependently thechroma- 
tin condensation i duced in serum-free medium, which also 
confirmed literature reports [22]. 
3. : .  Induction of chromatin condensation by bafilomycin A1 
requires de novo synthesis of  protein and is inhibited by 
ATA 
Fig. 4A shows the effect of cycloheximide (CHX) on the 
ctlromatin condensation i duced by bafilomycin A1. About 
5(% of the chromatin condensation i duced by bafilomycin 
3.4. DNA fragmentation of  PC12 cells treated with bafilomycin 
A1 
Fig. 5 shows the fragmentation f DNA obtained from cells 
treated with bafilomycin A1. Bafilomycin A1 induced DNA 
fragmentation time- and dose-dependently, with maximum 
fragmentation attained at 48 h with 500 nM bafilomycin A1 
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Fig. 3. Time course and dose response of bafilomycin Al-induced morphological changes of PC12 cells. Cells were scored for NOG and chro- 
matin condensation asdescribed in Section 2 after incubation with bafilomycin A1. A: Time course. (n) NOG at 30 nM; (11) chromatin con- 
densation at 125 n M. B: Dose response at 36 h. (O) NOG; (O) chromatin condensation. Means + S.D. of triplicates are plotted. 
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Fig. 4. Effects of cycloheximide (CHX) and aurintricarboxylic a id 
(ATA) on the induction of apoptosis in PC12 cells. Cells were 
scored for chromatin condensation as described in Section 2 after 
incubation in medium containing 125 nM bafilomycin A1 for 36 h 
(closed bar) or in serum-free medium for 24 h (open bar) with or 
without CHX (A) and ATA (B). 
in parallel with chromatin condensation, but NH4CI up to 10 
mM did not (data not shown). 
3.5. Effect of NH4CI on the bafilomycin Al-induced apoptosis 
of PC12 cells 
Like NH4C1 (10 mM) (and various weak bases) [18,23], 
bafilomycin A1 (100 nM) increases vacuolar pH to neutrality 
[7,24] and inhibits cell growth completely [9,25]. However, 
only bafilomycin A1 induced apoptotic hromatin condensa- 
tion in PC12 cells (Fig. 2B), suggesting that vacuolar alkali- 
nization has nothing to do with, or is at least insufficient for, 
the induction of apoptosis. What causes these divergent effects 
of NH4C1 and bafilomycin AI? Unlike NH4CI, bafilomycin 
A] might decrease cytosolic pH through inhibition of plasma 
membrane V-ATPase, if any [26]. Therefore, the divergent 
effects of these drugs might have originated from their differ- 
ential effect on cytosolic pH. In fact, 125 nM bafilomycin A1 
sometimes decreased the cytosolic pH of PC12 cells, but only 
slightly (<0.1 pH unit) and transiently (<  10 min), if at all, 
in complete medium and resulted in little decrease in cytosolic 
pH in the long run (Fig. 6C). Furthermore, the cytosolic pH 
in the presence or absence of bafilomycin A1 was raised close 
to medium pH by 10 mM NH4C1 (Fig. 6C), but neither the 
induction of cell death (Fig. 6A) nor that of chromatin con- 
densation (Fig. 6B) in the bafilomycin Al-treated cells was 
affected by 10 mM NHnC1. Similar observations were made 
with chloroquine instead of NH4C1 (data not shown). These 
findings suggest that bafilomycin Aa-induced apoptosis in 
PC12 cells is triggered neither by simple vacuolar alkaliniza- 
tion nor by cytosolic acidification. 
4. Discussion 
We examined the nature of cell growth inhibition by bail- 
lomycin A1 as compared with that of NHnC1. Although both 
bafilomycin A1 and NH4CI arrested cell growth [9] (probably 
at the G0/G1 phase of the cell cycle), only bafilomycin A] 
induced chromatin condensation (morphological marker of 
apoptosis [15]) eventually leading to cell death. (Higher con- 
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centrations (->40 mM) of NH4CI induced apoptotic hanges 
with peculiar characteristics (unpublished observation).) The 
chromatin condensation i duced by bafilomycin A1 was not 
due to its general degenerative effect, because similar chroma- 
tin condensation was not induced by other metabolic inhibi- 
tors tested including potassium cyanide (data not shown). 
Furthermore, the chromatin condensation was inhibited by 
CHX, suggesting its dependence on active de novo synthesis 
of protein, which is another important criterion for apoptosis: 
gene-regulated active cell death [27]. However, protein synth- 
esis is not necessarily involved in every type of apoptosis: 
CHX has no effect on the apoptosis induced in serum-free 
medium, like staurosporine-induced apoptosis [28] (Fig. 5 
and [18]). The bafilomycin Al-induced apoptosis was also in- 
hibited by ATA, an inhibitor of endonucleases [21], suggesting 
the participation in this apoptosis of endonuclease which will 
eventually lead to DNA fragmentation [22]. In fact, ladder 
formation of DNA (a biochemical marker of apoptosis [16]) 
was clearly observed in cells treated with bafilomycin A1 (Fig. 
5 and [13]). 
Recently, evidence has accumulated that acidifcation of 
cytosolic pH is associated with, and sometimes even essential 
for, some types of apoptosis [29-32], among which the partic- 
ipation of V-ATPase has been suggested to exclude protons 
from the cytosol. Therefore, the decrease of cytosolic pH, 
rather than the increase in vacuolar pH, might be the trigger 
for the apoptotic hange induced by bafilomycin AI. In fact, 
vacuolar pH was raised not only by bafilomycin A1 [7,9,10] 
(pH increased to 5.9 and 6.6 from 5.0 at 100 and 500 nM in 
PC12 cells [7]) but also by NH4CI (pH increased to ->6.4 at 10 
mM [18,23]), while the cytosolic pH was raised by NH4C1 but 
decreased by bafilomycin A1 [26]. However, as shown in this 
study, the cytosolic pH of PC12 cells remained normal in 
complete medium, probably through Na+/H+-antiporter ac- 
tivity, although cytosolic pH sometimes showed a small and 
transient decrease, and, after 24 h, the apoptotic ell popula- 
tion with acidic cytosol appeared in flow cytometry probably 
to Bafilomycin A1 
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Fig. 5. DNA ladder formation of PC12 cells treated with bafilomy- 
cin A1. The DNA extracted from cells after incubation in the fol- 
lowing conditions was electrophoresed on 2% agarose gel and 
stained with 0.5 ~tg/ml of ethidium bromide for 10 min. 
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Fig 6. Effect of NH4CI on the cell viability, apoptosis and cytosolic pH of bafllomycin Aa-treated PCI2 cells. Cells were either scored for cell 
viability (A) or for chromatin condensation (B) or loaded with BCECF to estimate cytosolic pH (C) as described in Section 2, at the end of in- 
cubation under the indicated conditions. (B) complete medium: (©) 125 nM bafilomycin AI: (D) 10 mM NH4CI; (o) 125 nM bafilomycin 
AI 10 mM NH4Cl. 
secmdary to apoptotic change (unpublished observation). 
Fu'thermore, the cytosolic pH of PC12 cells was raised by 
10 mM NH4C1 regardless of the presence or absence of bail- 
lomycin A1. However, bafilomycin Al-induced apoptosis was 
no~ affected by the increase of cytosolic pH by 10 mM NH4C1 
(F,g. 6). These findings suggest hat bafilomycin Al-induced 
ap,,ptosis in PC12 cells does not require cytosolic acidifica- 
tiol. Essentially the same conclusion was reached in a study 
of ~afilomycin Al-induced apoptosis in HL60 leukemic mye- 
loi, l precursor cells (Kurashima et al., manuscript in prepara- 
tio 1). 
Both bafilomycin A1 and NH4C1 increase the pH of vacuo- 
lal organdies and arrest cells at a specific stage of the cell 
cy~ le, probably by depriving cells of necessary nutrients uch 
as ferric ions [11,33] and/or growth factors like FGF  [34,35]. 
At:er a period of arrest at the G0/G1 stage, cells cannot per- 
fo~ m normal DNA synthesis. According to the 'death by de- 
fal It hypothesis' [36] or 'Gl-arrest hypothesis' [37,38], it will 
tri!:ger the cells into the apoptotic death cascade. However, 
on y bafilomycin Al-treated cells entered the apoptotic proc- 
ess Furthermore, NH4CI did not interfere with the apoptotic 
pr,.cess induced by bafilomycin A1. These results suggest hat 
vacuolar alkalinization alone is, at least, insufficient for the 
incuction of apoptosis. The divergence of these effects be- 
tw,:en bafilomycin Aj and NH4CI in the induction of apop- 
to>is is quite similar to that in the induction of NOG: NH4C1 
neither induced NOG nor suppressed NOG induced by bafi- 
lo; wcin A1 [7]. As will be shown separately, bafilomycin A1- 
int uced NOG requires participation of a protein phosphory- 
lal on-dephosphorylation cycle of signal transduction (Wari- 
taxi et al., and Noto et al., manuscripts in preparation). 
Tl~erefore, there may be serious differences in the signal trans- 
du :tion cascade between bafilomycin Al-treated and NH,C1- 
trctted ceils, and these require further study. 
~rogrammed cell death may also play a pivotal role in 
en bryogenesis, immune system maturation, and tissue home- 
os asis [26,39]. From these points of view, the correlation 
be ween apoptosis and cell differentiation should also be ex- 
an ined extensively. Bafilomycins, like retinoic acid (on human 
en bryonal carcinoma cells) [40], induce cell differentiation 
ar t  apoptosis at the same time. Bafilomycin Al-induced 
ap~ptosis is suppressed by other neuritogenic agents and ac- 
ceierated by agents that inhibit cell differentiation (manuscript 
in preparation). Furthermore, cell differentiation and apopto- 
sis are both important to cancer therapy, since cancer cells can 
be selectively eliminated by artificially triggering either their 
differentiation or their death through apoptosis: transplanted 
invasive human pancreatic ancer cells which express a high 
level of V-ATPase subunit proteins [41] have been selectively 
induced to die of apoptosis by bafilomycin A1 in the host 
nude mice [42]. 
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